Enable Injections’ enFuse Syringe Transfer System has secured CE mark approval under the European Union Medical Device ...

Newronika announced today that it received CE mark approval for its AlphaDBS device for treating Parkinson's disease.

With PFA becoming physicians’ preferred ablation method for treating AFib, Abbott is pushing to catch up with rival systems ...

Newronika has secured CE Mark approval for its AlphaDBS device aimed at the treatment of Parkinson's disease (PD), in Europe.

Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...

“Impulse Dynamics has established leadership and commitment to significantly changing the treatment options available for HF patients,” said Jason Spees, CEO of Impulse Dynamics. “The expanded ...

Enable is currently working with a number of pharmaceutical partners to conduct clinical trials and plan for joint commercial launch of their therapies in combination with the enFuse technology. The ...

The company is first rolling out the use of the Volt system among European Union doctors who have already gained experience ...

Abbott Park, Illinois Saturday, March 29, 2025, 13:00 Hrs [IST] ...

today announced it has received its European Union Medical Device Regulation (EU MDR) CE Mark approval of the enFuse Syringe Transfer System. This approval allows Enable to deliver its innovative ...